Get started
Author

Oscar Aubi

Observed names: Aubi, Oscar, O. Aubi
ORCID: 0000-0002-8332-3862
Observed ORCID: 0000-0002-8332-3862
OpenAlex ID: A5068527957
Phenylalanine Hydroxylase Misfolding and Pharmacological Chaperones
2013 · Jarl Underhaug, Oscar Aubi, et al. · Current Topics in Medicinal Chemistry · 67
PDF
EU-OPENSCREEN: A Novel Collaborative Approach to Facilitate Chemical Biology
2019 · Philip Brennecke, Dace Rasina, et al. · SLAS DISCOVERY · 33
The Pah-R261Q mouse reveals oxidative stress associated with amyloid-like hepatic aggregation of mutant phenylalanine hydroxylase
2021 · Oscar Aubi, Karina S. Prestegård, et al. · Nature Communications · 30
PDF
Phenylalanine Hydroxylase from Legionella pneumophila Is a Thermostable Enzyme with a Major Functional Role in Pyomelanin Synthesis
2012 · Marte I. Flydal, Christa H. Chatfield, et al. · PLoS ONE · 29
PDF
Discovery of a Specific Inhibitor of Pyomelanin Synthesis in Legionella pneumophila
2015 · Oscar Aubi, Marte I. Flydal, et al. · Journal of Medicinal Chemistry · 15
Conformational stabilization as a strategy to prevent nucleophosmin mislocalization in leukemia
2017 · María A. Urbaneja, Lars Skjærven, et al. · Scientific Reports · 13
PDF
Early Stage Discovery and Validation of Pharmacological Chaperones for the Correction of Protein Misfolding Diseases
2018 · Oscar Aubi, Per M. Knappskog, et al. · Methods in molecular biology · 8
216 (PB204): The mechanistic basis of both deep and durable antitumor activity by combinatorial inhibition of MAT2A and PRMT5 in MTAP-deleted tumors
2024 · D. Garbett, A.A. Rao, et al. · European Journal of Cancer · 2
Abstract 4483: The KAT6/7 inhibitor IDE574 disrupts tumor lineage identity and drug tolerance to deliver robust antitumor activity in biomarker selected indications.
2026 · Manav Gupta, Scott R. Tyler, et al. · Cancer Research · 1
Abstract 4504: The impact of metabolite kinetics on dysregulation of essential enzymes in cancers with MTAP deficiencies
2025 · Oscar Aubi, Shannon Faris, et al. · Cancer Research · 1
Abstract 4505: IDE892 is a highly potent and selective PRMT5 inhibitor, with MTA-positive and SAM-negative cooperativity, optimized for development in MTAPdel cancers in combination with the allosteric MAT2A inhibitor IDE397.
2026 · Arjun A. Rao, Marcus M. Fischer, et al. · Cancer Research
Phenylalanine Hydroxylase Misfolding and Pharmacological Chaperones
2013 · Jarl Underhaug, Oscar Aubi, et al. · Current Topics in Medicinal Chemistry
Works count: 14
Citation count: 199
H-index: 7
I10-index: 6
Year
Topic
Type